secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rallybio Corp (RLYB)
CIK:        0001739410
Form:       8-K
Filed at:   2022-04-04T23:59:59+00:00
Accession:  0000950170-22-005307
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rallybio appoints Christine Nash and Hui Liu to board; Shannon to resign at annual meeting
--------------------------------------------------------------------------------

- Board size increased from 8 to 10; Christine Nash and Hui Liu appointed as directors effective April 4, 2022.
- Nash appointed to Compensation Committee; Liu appointed to Audit Committee.
- Director Timothy Shannon to resign at Rallybio's 2022 annual meeting of shareholders.
- Nash brings rare disease commercial/product launch experience; Liu brings business development and finance expertise.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739410/000095017022005307/0000950170-22-005307-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739410/000095017022005307/rlyb-20220401.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-005307

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer